JAMES PRATT: Open Payments
NPI 1649720517 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 28 payments from 10 companies in 2025. Trend: 2023 $405 · 2024 $246 · 2025 $527
Food & beverage: $447Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $176 |
| ABBVIE INC. | 4 | $77 |
| UCB, Inc. | 4 | $77 |
| LEO Pharma Inc. | 3 | $56 |
| Amgen Inc. | 3 | $48 |
| Incyte Corporation | 3 | $44 |
| Lilly USA, LLC | 1 | $17 |
| GENZYME CORPORATION | 1 | $15 |
| Organon LLC | 1 | $9 |
| BioWound Solutions, Inc. | 1 | $8 |
Products named: TREMFYA, Bimzelx, OTEZLA, OPZELURA, RINVOQ, ADBRY, SKYRIZI, ANZUPGO.
Industry payments across MT — which companies pay providers there.
